カテゴリー： Stratistics MRC, 世界, 医療/バイオ

ヒトインスリンの世界市場予測（～2027年）

◆英語タイトル：Human Insulin Market Forecasts to 2028 – Global Analysis By Product Type (Traditional Human Insulin, Insulin Analogs and Biosimilars and Other Product Types), Diabetes Type (Type I Diabetes, Type II Diabetes and Other Diabetes Types), Distribution Channel and By Geography

Stratistics MRCが発行した調査報告書（SMR23MR012）◆商品コード：SMR23MR012
◆発行会社（リサーチ会社）：Stratistics MRC
◆発行日：2022年12月
◆ページ数：約150
◆レポート形式：英語 / Eメール
◆納品方法：英語
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Global Site LicenseUSD4,150 ⇒換算￥630,800見積依頼/購入/質問フォーム
PDFUSD7,500 ⇒換算￥1,140,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）

❖ レポートの概要 ❖

ストラティスティックスMRC社は、世界のヒトインスリン市場規模が2022年187億ドルから2028年248億ドルになり、予測期間中に年平均4.7%で成長すると予測しています。本報告書では、ヒトインスリンの世界市場を調査し、エグゼクティブサマリー、序論、市場動向分析、ファイブフォース分析、製品種類別（従来型ヒトインスリン、インスリンアナログ＆バイオシミラー、その他）分析、糖尿病種類別（I型糖尿病、II型糖尿病、その他）分析、流通チャネル別（小売店＆オンライン薬局、病院薬局、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、南米、中東・アフリカ）分析、最近の動向、企業情報など、次のように掲載しています。また、企業情報としては、Eli Lilly and Company, Novo Nordisk A/S, Tonghua Dongbao Pharmaceutical Co. Ltd., Julphar, Biocon Ltd, Sanofi, United Laboratories International Holdings Limited, Pfizer, Inc., Boehringer Ingelheim International GmbHなどが含まれています。
・エグゼクティブサマリー
・序論
・市場動向分析
・ファイブフォース分析
・世界のヒトインスリン市場規模：製品種類別
- 従来型ヒトインスリンの市場規模
- インスリンアナログ＆バイオシミラーの市場規模
- その他製品の市場規模
・世界のヒトインスリン市場規模：糖尿病種類別
- I型糖尿病の市場規模
- II型糖尿病の市場規模
- その他糖尿病の市場規模
・世界のヒトインスリン市場規模：流通チャネル別
- 小売店＆オンライン薬局チャネルの市場規模
- 病院薬局チャネルの市場規模
- その他流通チャネルの市場規模
・世界のヒトインスリン市場規模：地域別
- 北米のヒトインスリン市場規模
- ヨーロッパのヒトインスリン市場規模
- アジア太平洋のヒトインスリン市場規模
- 南米のヒトインスリン市場規模
- 中東・アフリカのヒトインスリン市場規模
・最近の動向
・企業情報

According to Stratistics MRC, the Global Human Insulin Market is accounted for $18.7 billion in 2022 and is expected to reach $24.8 billion by 2028 growing at a CAGR of 4.7% during the forecast period. Human insulin (HI) is a short-acting form of insulin used to treat hyperglycemia caused by type-1 and type-2 diabetes. It is produced by recombinant DNA technology and identical to endogenously made insulin. It is used to take the place of insulin generally produced by the body and aids in insulating sugar from the blood into other body tissues, wherein it is utilized for energy. Insulin is a hormone made by the beta cells of the pancreas. It plays a vital role in the regulation of glucose levels. It controls the body’s systems and regulates the uptake of amino acids by body cells.

According to the Centers for Disease Control and Prevention, around 1.6 million adults aged 20 years or older have Type 1 diabetes and use insulin. According to the Asian Diabetes Prevention Initiative, people in Asia are at a high risk of developing diabetes due to lifestyle and diet trends.

Key players in the market

Some of the key players profiled in the Human Insulin Market include Eli Lilly and Company, Novo Nordisk A/S, Tonghua Dongbao Pharmaceutical Co. Ltd., Julphar, Biocon Ltd, Sanofi, United Laboratories International Holdings Limited, Pfizer, Inc., Boehringer Ingelheim International GmbH, Wockhardt, Bristol-Myers Squibb Company., Oramed Pharmaceuticals, Inc., GlaxoSmithKline Plc., Gan & Lee Pharmaceuticals Co Ltd., Ypsomed AG and Shanghai Fosun Pharmaceutical Co., Ltd.

Key Developments:

In November 2021, Novo Nordisk A/s acquired Dicerna Pharmaceuticals, including its Dicerna’s ribonucleic acid interference (RNAi) platform, in addition to Novo Nordisk’s research technology platforms used across all therapeutic areas.

In February 2021, Biocon Biologics partnered with the International Diabetes Federation (IDF) as the first biosimilar insulin company to promote and support IDF’s important mission initiative. The collaboration marks the start of the centennial commemoration of the invention of insulin and advances Biocon Biologics’ aim of providing inexpensive insulin to individuals with diabetes around the world.

Product Types Covered:
• Traditional Human Insulin
• Insulin Analogs and Biosimilars
• Others Product Types

Diabetes Types Covered:
• Type I Diabetes
• Type II Diabetes
• Other Diabetes Types

Distribution Channels Covered:
• Retail & Online Pharmacies
• Hospitals Pharmacies
• Other Distribution Channels

Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

❖ レポートの目次 ❖

1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Human Insulin Market, By Product Type
5.1 Introduction
5.2 Traditional Human Insulin
5.2.1 Short-Acting Biologics
5.2.2 Intermediate-Acting Biologics
5.2.3 Premixed Biologics
5.3 Insulin Analogs and Biosimilars
5.3.1 Rapid-Acting Biosimilars
5.3.2 Long-Acting Biosimilars
5.3.3 Premix Biosimilars
5.4 Other Product Types
6 Global Human Insulin Market, By Diabetes Type
6.1 Introduction
6.2 Type I Diabetes
6.3 Type II Diabetes
6.4 Other Diabetes Types
7 Global Human Insulin Market, By Distribution Channel
7.1 Introduction
7.2 Retail & Online Pharmacies
7.3 Hospitals Pharmacies
7.4 Other Distribution Channels
8 Global Human Insulin Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Eli Lilly and Company
10.2 Novo Nordisk A/S
10.3 Tonghua Dongbao Pharmaceutical Co. Ltd.
10.4 Julphar
10.5 Biocon Ltd
10.6 Sanofi
10.7 United Laboratories International Holdings Limited
10.8 Pfizer, Inc.
10.9 Boehringer Ingelheim International GmbH
10.10 Wockhardt
10.11 Bristol-Myers Squibb Company.
10.12 Oramed Pharmaceuticals, Inc.
10.13 GlaxoSmithKline Plc.
10.14 Gan & Lee Pharmaceuticals Co Ltd.
10.15 Ypsomed AG
10.16 Shanghai Fosun Pharmaceutical Co., Ltd
List of Tables
Table 1 Global Human Insulin Market Outlook, By Region (2020-2028) ($MN)
Table 2 Global Human Insulin Market Outlook, By Product Type (2020-2028) ($MN)
Table 3 Global Human Insulin Market Outlook, By Traditional Human Insulin (2020-2028) ($MN)
Table 4 Global Human Insulin Market Outlook, By Short-Acting Biologics (2020-2028) ($MN)
Table 5 Global Human Insulin Market Outlook, By Intermediate-Acting Biologics (2020-2028) ($MN)
Table 6 Global Human Insulin Market Outlook, By Premixed Biologics (2020-2028) ($MN)
Table 7 Global Human Insulin Market Outlook, By Insulin Analogs and Biosimilars (2020-2028) ($MN)
Table 8 Global Human Insulin Market Outlook, By Rapid-Acting Biosimilars (2020-2028) ($MN)
Table 9 Global Human Insulin Market Outlook, By Long-Acting Biosimilars (2020-2028) ($MN)
Table 10 Global Human Insulin Market Outlook, By Premix Biosimilars (2020-2028) ($MN)
Table 11 Global Human Insulin Market Outlook, By Other Product Types (2020-2028) ($MN)
Table 12 Global Human Insulin Market Outlook, By Diabetes Type (2020-2028) ($MN)
Table 13 Global Human Insulin Market Outlook, By Type I Diabetes (2020-2028) ($MN)
Table 14 Global Human Insulin Market Outlook, By Type II Diabetes (2020-2028) ($MN)
Table 15 Global Human Insulin Market Outlook, By Other Diabetes Types (2020-2028) ($MN)
Table 16 Global Human Insulin Market Outlook, By Distribution Channel (2020-2028) ($MN)
Table 17 Global Human Insulin Market Outlook, By Retail & Online Pharmacies (2020-2028) ($MN)
Table 18 Global Human Insulin Market Outlook, By Hospitals Pharmacies (2020-2028) ($MN)
Table 19 Global Human Insulin Market Outlook, By Other Distribution Channels (2020-2028) ($MN)
Table 20 North America Human Insulin Market Outlook, By Country (2020-2028) ($MN)
Table 21 North America Human Insulin Market Outlook, By Product Type (2020-2028) ($MN)
Table 22 North America Human Insulin Market Outlook, By Traditional Human Insulin (2020-2028) ($MN)
Table 23 North America Human Insulin Market Outlook, By Short-Acting Biologics (2020-2028) ($MN)
Table 24 North America Human Insulin Market Outlook, By Intermediate-Acting Biologics (2020-2028) ($MN)
Table 25 North America Human Insulin Market Outlook, By Premixed Biologics (2020-2028) ($MN)
Table 26 North America Human Insulin Market Outlook, By Insulin Analogs and Biosimilars (2020-2028) ($MN)
Table 27 North America Human Insulin Market Outlook, By Rapid-Acting Biosimilars (2020-2028) ($MN)
Table 28 North America Human Insulin Market Outlook, By Long-Acting Biosimilars (2020-2028) ($MN)
Table 29 North America Human Insulin Market Outlook, By Premix Biosimilars (2020-2028) ($MN)
Table 30 North America Human Insulin Market Outlook, By Other Product Types (2020-2028) ($MN)
Table 31 North America Human Insulin Market Outlook, By Diabetes Type (2020-2028) ($MN)
Table 32 North America Human Insulin Market Outlook, By Type I Diabetes (2020-2028) ($MN)
Table 33 North America Human Insulin Market Outlook, By Type II Diabetes (2020-2028) ($MN)
Table 34 North America Human Insulin Market Outlook, By Other Diabetes Types (2020-2028) ($MN)
Table 35 North America Human Insulin Market Outlook, By Distribution Channel (2020-2028) ($MN)
Table 36 North America Human Insulin Market Outlook, By Retail & Online Pharmacies (2020-2028) ($MN)
Table 37 North America Human Insulin Market Outlook, By Hospitals Pharmacies (2020-2028) ($MN)
Table 38 North America Human Insulin Market Outlook, By Other Distribution Channels (2020-2028) ($MN)
Table 39 Europe Human Insulin Market Outlook, By Country (2020-2028) ($MN)
Table 40 Europe Human Insulin Market Outlook, By Product Type (2020-2028) ($MN)
Table 41 Europe Human Insulin Market Outlook, By Traditional Human Insulin (2020-2028) ($MN)
Table 42 Europe Human Insulin Market Outlook, By Short-Acting Biologics (2020-2028) ($MN)
Table 43 Europe Human Insulin Market Outlook, By Intermediate-Acting Biologics (2020-2028) ($MN)
Table 44 Europe Human Insulin Market Outlook, By Premixed Biologics (2020-2028) ($MN)
Table 45 Europe Human Insulin Market Outlook, By Insulin Analogs and Biosimilars (2020-2028) ($MN)
Table 46 Europe Human Insulin Market Outlook, By Rapid-Acting Biosimilars (2020-2028) ($MN)
Table 47 Europe Human Insulin Market Outlook, By Long-Acting Biosimilars (2020-2028) ($MN)
Table 48 Europe Human Insulin Market Outlook, By Premix Biosimilars (2020-2028) ($MN)
Table 49 Europe Human Insulin Market Outlook, By Other Product Types (2020-2028) ($MN)
Table 50 Europe Human Insulin Market Outlook, By Diabetes Type (2020-2028) ($MN)
Table 51 Europe Human Insulin Market Outlook, By Type I Diabetes (2020-2028) ($MN)
Table 52 Europe Human Insulin Market Outlook, By Type II Diabetes (2020-2028) ($MN)
Table 53 Europe Human Insulin Market Outlook, By Other Diabetes Types (2020-2028) ($MN)
Table 54 Europe Human Insulin Market Outlook, By Distribution Channel (2020-2028) ($MN)
Table 55 Europe Human Insulin Market Outlook, By Retail & Online Pharmacies (2020-2028) ($MN)
Table 56 Europe Human Insulin Market Outlook, By Hospitals Pharmacies (2020-2028) ($MN)
Table 57 Europe Human Insulin Market Outlook, By Other Distribution Channels (2020-2028) ($MN)
Table 58 Asia Pacific Human Insulin Market Outlook, By Country (2020-2028) ($MN)
Table 59 Asia Pacific Human Insulin Market Outlook, By Product Type (2020-2028) ($MN)
Table 60 Asia Pacific Human Insulin Market Outlook, By Traditional Human Insulin (2020-2028) ($MN)
Table 61 Asia Pacific Human Insulin Market Outlook, By Short-Acting Biologics (2020-2028) ($MN)
Table 62 Asia Pacific Human Insulin Market Outlook, By Intermediate-Acting Biologics (2020-2028) ($MN)
Table 63 Asia Pacific Human Insulin Market Outlook, By Premixed Biologics (2020-2028) ($MN)
Table 64 Asia Pacific Human Insulin Market Outlook, By Insulin Analogs and Biosimilars (2020-2028) ($MN)
Table 65 Asia Pacific Human Insulin Market Outlook, By Rapid-Acting Biosimilars (2020-2028) ($MN)
Table 66 Asia Pacific Human Insulin Market Outlook, By Long-Acting Biosimilars (2020-2028) ($MN)
Table 67 Asia Pacific Human Insulin Market Outlook, By Premix Biosimilars (2020-2028) ($MN)
Table 68 Asia Pacific Human Insulin Market Outlook, By Other Product Types (2020-2028) ($MN)
Table 69 Asia Pacific Human Insulin Market Outlook, By Diabetes Type (2020-2028) ($MN)
Table 70 Asia Pacific Human Insulin Market Outlook, By Type I Diabetes (2020-2028) ($MN)
Table 71 Asia Pacific Human Insulin Market Outlook, By Type II Diabetes (2020-2028) ($MN)
Table 72 Asia Pacific Human Insulin Market Outlook, By Other Diabetes Types (2020-2028) ($MN)
Table 73 Asia Pacific Human Insulin Market Outlook, By Distribution Channel (2020-2028) ($MN)
Table 74 Asia Pacific Human Insulin Market Outlook, By Retail & Online Pharmacies (2020-2028) ($MN)
Table 75 Asia Pacific Human Insulin Market Outlook, By Hospitals Pharmacies (2020-2028) ($MN)
Table 76 Asia Pacific Human Insulin Market Outlook, By Other Distribution Channels (2020-2028) ($MN)
Table 77 South America Human Insulin Market Outlook, By Country (2020-2028) ($MN)
Table 78 South America Human Insulin Market Outlook, By Product Type (2020-2028) ($MN)
Table 79 South America Human Insulin Market Outlook, By Traditional Human Insulin (2020-2028) ($MN)
Table 80 South America Human Insulin Market Outlook, By Short-Acting Biologics (2020-2028) ($MN)
Table 81 South America Human Insulin Market Outlook, By Intermediate-Acting Biologics (2020-2028) ($MN)
Table 82 South America Human Insulin Market Outlook, By Premixed Biologics (2020-2028) ($MN)
Table 83 South America Human Insulin Market Outlook, By Insulin Analogs and Biosimilars (2020-2028) ($MN)
Table 84 South America Human Insulin Market Outlook, By Rapid-Acting Biosimilars (2020-2028) ($MN)
Table 85 South America Human Insulin Market Outlook, By Long-Acting Biosimilars (2020-2028) ($MN)
Table 86 South America Human Insulin Market Outlook, By Premix Biosimilars (2020-2028) ($MN)
Table 87 South America Human Insulin Market Outlook, By Other Product Types (2020-2028) ($MN)
Table 88 South America Human Insulin Market Outlook, By Diabetes Type (2020-2028) ($MN)
Table 89 South America Human Insulin Market Outlook, By Type I Diabetes (2020-2028) ($MN)
Table 90 South America Human Insulin Market Outlook, By Type II Diabetes (2020-2028) ($MN)
Table 91 South America Human Insulin Market Outlook, By Other Diabetes Types (2020-2028) ($MN)
Table 92 South America Human Insulin Market Outlook, By Distribution Channel (2020-2028) ($MN)
Table 93 South America Human Insulin Market Outlook, By Retail & Online Pharmacies (2020-2028) ($MN)
Table 94 South America Human Insulin Market Outlook, By Hospitals Pharmacies (2020-2028) ($MN)
Table 95 South America Human Insulin Market Outlook, By Other Distribution Channels (2020-2028) ($MN)
Table 96 Middle East & Africa Human Insulin Market Outlook, By Country (2020-2028) ($MN)
Table 97 Middle East & Africa Human Insulin Market Outlook, By Product Type (2020-2028) ($MN)
Table 98 Middle East & Africa Human Insulin Market Outlook, By Traditional Human Insulin (2020-2028) ($MN)
Table 99 Middle East & Africa Human Insulin Market Outlook, By Short-Acting Biologics (2020-2028) ($MN)
Table 100 Middle East & Africa Human Insulin Market Outlook, By Intermediate-Acting Biologics (2020-2028) ($MN)
Table 101 Middle East & Africa Human Insulin Market Outlook, By Premixed Biologics (2020-2028) ($MN)
Table 102 Middle East & Africa Human Insulin Market Outlook, By Insulin Analogs and Biosimilars (2020-2028) ($MN)
Table 103 Middle East & Africa Human Insulin Market Outlook, By Rapid-Acting Biosimilars (2020-2028) ($MN)
Table 104 Middle East & Africa Human Insulin Market Outlook, By Long-Acting Biosimilars (2020-2028) ($MN)
Table 105 Middle East & Africa Human Insulin Market Outlook, By Premix Biosimilars (2020-2028) ($MN)
Table 106 Middle East & Africa Human Insulin Market Outlook, By Other Product Types (2020-2028) ($MN)
Table 107 Middle East & Africa Human Insulin Market Outlook, By Diabetes Type (2020-2028) ($MN)
Table 108 Middle East & Africa Human Insulin Market Outlook, By Type I Diabetes (2020-2028) ($MN)
Table 109 Middle East & Africa Human Insulin Market Outlook, By Type II Diabetes (2020-2028) ($MN)
Table 110 Middle East & Africa Human Insulin Market Outlook, By Other Diabetes Types (2020-2028) ($MN)
Table 111 Middle East & Africa Human Insulin Market Outlook, By Distribution Channel (2020-2028) ($MN)
Table 112 Middle East & Africa Human Insulin Market Outlook, By Retail & Online Pharmacies (2020-2028) ($MN)
Table 113 Middle East & Africa Human Insulin Market Outlook, By Hospitals Pharmacies (2020-2028) ($MN)
Table 114 Middle East & Africa Human Insulin Market Outlook, By Other Distribution Channels (2020-2028) ($MN)



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ ヒトインスリンの世界市場予測（～2027年）(Human Insulin Market Forecasts to 2028 – Global Analysis By Product Type (Traditional Human Insulin, Insulin Analogs and Biosimilars and Other Product Types), Diabetes Type (Type I Diabetes, Type II Diabetes and Other Diabetes Types), Distribution Channel and By Geography)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • ヒトインスリンのグローバル市場（～2027）：従来型ヒトインスリン、インスリンアナログ＆バイオシミラー、その他
  • インスリンポンプの世界市場予測（～2027年）
  • ヒトインスリン薬剤の世界市場（2023-2028）
  • インスリンポンプのグローバル市場（～2027）：テザーポンプ、パッチポンプ
  • ヒトインスリンの世界市場2024～2032：製品種類別、流通チャネル別、疾患種類別、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆